Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease

Luis D'Marco1, María Jesús Puchades1,2, Nayara Panizo1

  • 1Nephrology Department, Hospital Clínico Universitario, Institute of Health Research (INCLIVA), Valencia, Spain.

Frontiers in Medicine
|June 11, 2021
PubMed

Insights

Epicardial and perirenal fat deposits are linked to heart and kidney disease. Understanding how these fats impact cardiorenal dysfunction in chronic kidney disease (CKD) is crucial for patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Background:

  • Growing interest in adipose tissue's role in cardiac and renal pathophysiology.
  • Epicardial fat and perirenal fat are linked to adverse outcomes in chronic kidney disease (CKD) patients.
  • These fat depots may connect vascular and cardiorenal disease.

Purpose of the Study:

  • To explore the links between epicardial and perirenal fat.
  • To elucidate their role in modulating cardiorenal dysfunction in CKD patients.

Main Methods:

  • Review of current scientific literature.
  • Analysis of studies investigating epicardial and perirenal fat in relation to cardiovascular and renal health.
  • Exploration of the pathophysiological mechanisms involved.

Main Results:

  • Epicardial fat secretes inflammatory cytokines, promoting atherosclerosis.
  • Perirenal fat shows a strong correlation with kidney diseases and is an independent risk factor for CKD progression.
  • Both fat depots are associated with cardiorenal dysfunction.

Conclusions:

  • Epicardial and perirenal fat act as key modulators of cardiorenal dysfunction in CKD.
  • Further research into these specific adipose depots is clinically important for managing cardiorenal disease.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
224
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
112
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
300
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
576
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
565
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
635